Literature DB >> 12357093

Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.

Anita Holzinger1, Watter Loffler, Peter Muller, Stefan Priebe, Matthias C Angermeyer.   

Abstract

This study investigates subjective illness theories of patients with schizophrenia, how they define their health problem, what they assume causes their illness and which course of illness they expect. The predictive value of those theories for patients' compliance with antipsychotic medication is tested. A problem-centered interview was conducted with 77 schizophrenic patients at discharge from inpatient or day hospital treatment. All patients were on clozapine treatment. Interviews were analyzed by means of computer-assisted content analysis. In addition, potential determinants of compliance were assessed using the 9th version of the Present State Examination, the UKU side effect rating scale, a checklist for patients' evaluations of the effect of psychotropic drugs, and a helping alliance scale. Compliance with medication was assessed by interviewing patients at discharge and three months later. Only slightly more than one half of the patients considered themselves mentally ill. They tended to endorse psychosocial causes more frequently as compared with biological causes. Slightly more than 25% of the patients each expected an improvement of the illness, a reoccurrence of the acute psychosis, or a chronic course. Whereas the quality of the helping alliance, delusion of grandiosity, and attitude toward psychotropic drugs proved to have an influence on patients' compliance with antipsychotic treatment, the three components of subjective illness theory (definition as mental illness, assumed etiology, and prognosis) did not have a statistically significant influence. Subjective illness theories vary in patients with schizophrenia. Although they might reflect different styles of coping with the illness, there is no evidence that they directly determine compliance with medication. Patients' views of the helping alliance and attitudes toward drugs should be considered in predicting compliance with antipsychotic medication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12357093     DOI: 10.1097/01.NMD.0000030524.45210.FD

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  12 in total

Review 1.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

2.  Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.

Authors:  Christine M Wilder; Eric B Elbogen; Lorna L Moser; Jeffrey W Swanson; Marvin S Swartz
Journal:  Psychiatr Serv       Date:  2010-04       Impact factor: 3.084

3.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

4.  Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis.

Authors:  Steffen Moritz; Jerome Favrod; Christina Andreou; Anthony P Morrison; Francesca Bohn; Ruth Veckenstedt; Peter Tonn; Anne Karow
Journal:  Schizophr Bull       Date:  2012-02-15       Impact factor: 9.306

Review 5.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

6.  Factors associated with dropout from treatment: An exploratory study.

Authors:  Sandeep Grover; Sridhar Mallnaik; Subho Chakrabarti; Aseem Mehra
Journal:  Indian J Psychiatry       Date:  2021-02-15       Impact factor: 1.759

7.  The therapeutic relationship and adherence to antipsychotic medication in schizophrenia.

Authors:  Rosemarie McCabe; Jens Bullenkamp; Lars Hansson; Christoph Lauber; Rafael Martinez-Leal; Wulf Rössler; Hans Joachim Salize; Bengt Svensson; Francisco Torres-Gonzalez; Rob van den Brink; Durk Wiersma; Stefan Priebe
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

8.  Poor response to treatment: beyond medication.

Authors:  César Carvajal
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

9.  Assessment of impact of pharmacophilia and pharmacophobia on medication adherence in patients with psychiatric disorders: A cross-sectional study.

Authors:  Mini Johnson Christudas; Balaji Sathyanarayana Gupta; Krishna Undela; Noel M Isaac; Dushad Ram; Madhan Ramesh
Journal:  Indian J Pharmacol       Date:  2016 Nov-Dec       Impact factor: 1.200

Review 10.  Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care.

Authors:  Wai Tong Chien; Sau Fong Leung; Frederick Kk Yeung; Wai Kit Wong
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-25       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.